Compare metabolites in 2 of these studies:
Study A:   Study B:  

List of Studies ( Metabolite:PS 20:2/20:2)

Study_idAnalysis_idStudy_titleSourceSpeciesDiseaseInstituteAnalysis Type
ST004167 AN006918 Targeted Lipidomic Profiling of STBD1 Knockdown in Clear Cell Renal Carcinoma Cells Renal cancer cells Human Cancer The Affiliated Cancer Hospital of Zhengzhou University LC-MS
ST004118 AN006829 Lipidomics on Hep3B Cells Overexpressing CGI-158 and PNPLA2 Cultured cells Human Liver disease; Cancer Amgen LC-MS
ST003468 AN005701 Lipidomics of mice spleen to support understanding of early metabolic shift in presymptomatic sepsis patients. (Part13 mice spleen lipid) Spleen Mouse Sepsis Leibniz Institute for Natural Product Research and Infection Biology Hans Knöll Institute LC-MS
ST003465 AN005696 Lipidomics of mice kidney to support understanding of early metabolic shift in presymptomatic sepsis patients. (Part10 mice kidney lipid) Kidney Mouse Sepsis Leibniz Institute for Natural Product Research and Infection Biology Hans Knöll Institute LC-MS
ST002505 AN004127 A Mammalian Conserved Circular RNA CircLARP2 Regulates Hepatocellular Carcinoma Metastasis and Lipid Metabolism (Part 1) Cultured cells Human Cancer University of Science and Technology of China LC-MS
ST002303 AN003764 Fitm2 is required for ER homeostasis and normal function of murine liver Liver Mouse Harvard School of Public Health LC-MS
ST001687 AN002755 Non-transformed cells respond to fat by inducing glucose metabolism Liver Mouse VIB-KU Leuven Center for Cancer Biology LC-MS
  logo